| human | Q5 |
| P269 | IdRef ID | 197471137 |
| P496 | ORCID iD | 0000-0002-7426-432X |
| P1153 | Scopus author ID | 7003447882 |
| P4012 | Semantic Scholar author ID | 6825215 |
| P214 | VIAF ID | 610148705736237080004 |
| P108 | employer | University of Pennsylvania | Q49117 |
| P735 | given name | Boris | Q666112 |
| Boris | Q666112 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36386240 | A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis |
| Q92969332 | A Genetically Tractable, Natural Mouse Model of Cryptosporidiosis Offers Insights into Host Protective Immunity |
| Q34523529 | A MORN-repeat protein is a dynamic component of the Toxoplasma gondii cell division apparatus |
| Q33843880 | A Plastid Protein That Evolved from Ubiquitin and Is Required for Apicoplast Protein Import in Toxoplasma gondii. |
| Q27321038 | A Toxoplasma MORN1 null mutant undergoes repeated divisions but is defective in basal assembly, apicoplast division and cytokinesis |
| Q30573321 | A dynamin is required for the biogenesis of secretory organelles in Toxoplasma gondii |
| Q112636497 | A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition |
| Q35570700 | A novel bipartite centrosome coordinates the apicomplexan cell cycle |
| Q30573326 | A novel dynamin-related protein has been recruited for apicoplast fission in Toxoplasma gondii |
| Q37517724 | A nucleolar AAA-NTPase is required for parasite division |
| Q26851900 | A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium |
| Q28475058 | A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase |
| Q27972570 | A systematic screen to discover and analyze apicoplast proteins identifies a conserved and essential protein import factor |
| Q54458658 | Adenosine kinase from Cryptosporidium parvum. |
| Q105279479 | An Alveolata secretory machinery adapted to parasite host cell invasion. |
| Q27974703 | An apicoplast localized ubiquitylation system is required for the import of nuclear-encoded plastid proteins |
| Q33187462 | Analysis of the Sarcocystis neurona microneme protein SnMIC10: protein characteristics and expression during intracellular development. |
| Q35046030 | Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. |
| Q35762962 | Apicoplast and endoplasmic reticulum cooperate in fatty acid biosynthesis in apicomplexan parasite Toxoplasma gondii |
| Q35016560 | Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii |
| Q35102319 | Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. |
| Q63363557 | Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance inToxoplasma gondii |
| Q28742045 | Autophagy protein Atg3 is essential for maintaining mitochondrial integrity and for normal intracellular development of Toxoplasma gondii tachyzoites |
| Q36227292 | Autophagy-Related Protein ATG8 Has a Noncanonical Function for Apicoplast Inheritance in Toxoplasma gondii |
| Q35944460 | Beg, Borrow and Steal: Three Aspects of Horizontal Gene Transfer in the Protozoan Parasite, Cryptosporidium parvum |
| Q100394610 | Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase |
| Q35865647 | Building the perfect parasite: cell division in apicomplexa |
| Q38886453 | Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. |
| Q35009488 | CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes |
| Q27318477 | Cell division in Apicomplexan parasites is organized by a homolog of the striated rootlet fiber of algal flagella |
| Q38175274 | Cell division in apicomplexan parasites |
| Q40997338 | Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii |
| Q35956728 | Conditional mutagenesis of a novel choline kinase demonstrates plasticity of phosphatidylcholine biogenesis and gene expression in Toxoplasma gondii |
| Q59178752 | Constitutive Calcium-independent Release ofToxoplasma gondiiDense Granules Occurs through the NSF/SNAP/SNARE/Rab Machinery |
| Q59028924 | Criticism: what to do about science's bad public image? |
| Q39541748 | Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design |
| Q52671717 | Cryptosporidium. |
| Q33953731 | Daughter cell assembly in the protozoan parasite Toxoplasma gondii |
| Q43648958 | Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. |
| Q37099263 | Deploying parasite profilin on a mission of invasion and danger |
| Q43443980 | Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii |
| Q63363561 | Dynamics of Neutrophil Migration in Lymph Nodes during Infection |
| Q30541235 | Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node |
| Q30484144 | Dynamics of neutrophil migration in lymph nodes during infection |
| Q53969008 | Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. |
| Q36698210 | Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase |
| Q47871878 | Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. |
| Q30765361 | Fluorescent protein tagging in Toxoplasma gondii: identification of a novel inner membrane complex component conserved among Apicomplexa |
| Q33320191 | Forward genetic analysis of the apicomplexan cell division cycle in Toxoplasma gondii |
| Q36854287 | Gene transfer in the evolution of parasite nucleotide biosynthesis |
| Q39344334 | Generating and Maintaining Transgenic Cryptosporidium parvum Parasites |
| Q60621614 | Genetic Manipulation of Toxoplasma gondii |
| Q63363566 | Genetic Manipulation of Toxoplasma gondii |
| Q30701283 | Genetic complementation in apicomplexan parasites |
| Q37446287 | Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins |
| Q35072125 | Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering. |
| Q36268294 | Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. |
| Q31145546 | Genetic rescue of a Toxoplasma gondii conditional cell cycle mutant |
| Q35832557 | Genomics meets transgenics in search of the elusive Cryptosporidium drug target |
| Q63363569 | Glucosylation of Glycosylphosphatidylinositol Membrane Anchors: Identification of Uridine Diphosphate−Glucose as the Direct Donor for Side Chain Modification inToxoplasma gondiiUsing Carbohydrate Analogues† |
| Q63363572 | Glycosyl-phosphatidylinositols ofTrypanosoma congolense: Two Common Precursors but a New Protein-anchor |
| Q34725225 | High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein |
| Q33836711 | IMP dehydrogenase from the protozoan parasite Toxoplasma gondii |
| Q27313989 | Identification and characterization of Toxoplasma SIP, a conserved apicomplexan cytoskeleton protein involved in maintaining the shape, motility and virulence of the parasite. |
| Q33200456 | Identification of a sporozoite-specific member of the Toxoplasma SAG superfamily via genetic complementation |
| Q37612993 | In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites |
| Q59178745 | Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii |
| Q50077333 | Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. |
| Q59178742 | Isolation and Characterization of TgVP1, a Type I Vacuolar H+-translocating Pyrophosphatase fromToxoplasma gondii |
| Q93064917 | Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum |
| Q35168572 | Lipid kinases are essential for apicoplast homeostasis in Toxoplasma gondii |
| Q37315680 | Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans |
| Q112702442 | Live imaging of the Cryptosporidium parvum life cycle reveals direct development of male and female gametes from type I meronts |
| Q62997191 | Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis |
| Q36095373 | Make it or take it: fatty acid metabolism of apicomplexan parasites |
| Q47906362 | Malaria: The gatekeeper revealed |
| Q35213000 | Mining the Plasmodium genome database to define organellar function: what does the apicoplast do? |
| Q37708423 | Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii. |
| Q48086049 | Molecular genetic transfection of the coccidian parasite Sarcocystis neurona |
| Q47312150 | Molecular structure of the "low molecular weight antigen" of Toxoplasma gondii: a glucose alpha 1-4 N-acetylgalactosamine makes free glycosyl-phosphatidylinositols highly immunogenic. |
| Q34421163 | More membranes, more proteins: complex protein import mechanisms into secondary plastids |
| Q30540134 | Motile invaded neutrophils in the small intestine of Toxoplasma gondii-infected mice reveal a potential mechanism for parasite spread |
| Q38880229 | Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection |
| Q30041439 | Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum |
| Q27678115 | Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase |
| Q47141799 | PfClpC Is an Essential Clp Chaperone Required for Plastid Integrity and Clp Protease Stability in Plasmodium falciparum. |
| Q36570032 | Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum. |
| Q33221071 | Plastid segregation and cell division in the apicomplexan parasite Sarcocystis neurona |
| Q33855150 | Prodrug activation by Cryptosporidium thymidine kinase |
| Q36388796 | Protein sorting in complex plastids |
| Q33792570 | Sarcocystis neurona merozoites express a family of immunogenic surface antigens that are orthologues of the Toxoplasma gondii surface antigens (SAGs) and SAG-related sequences |
| Q36791988 | Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase |
| Q35787804 | Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. |
| Q35938640 | Studying the cell biology of apicomplexan parasites using fluorescent proteins |
| Q50853059 | Switching parasite proteins on and off. |
| Q54147735 | Tagging genes and trapping promoters in Toxoplasma gondii by insertional mutagenesis. |
| Q63363559 | Targeting Prokaryotic Enzymes in the Eukaryotic Pathogen Cryptosporidium |
| Q63363565 | Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis |
| Q36740182 | Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis |
| Q47882194 | Targeting and processing of nuclear-encoded apicoplast proteins in plastid segregation mutants of Toxoplasma gondii. |
| Q59178747 | Targeting of soluble proteins to the rhoptries and micronemes in Toxoplasma gondii |
| Q35767057 | Teaching old drugs new tricks to stop malaria invasion in its tracks |
| Q27972732 | The Import of Proteins into the Mitochondrion of Toxoplasma gondii |
| Q34354061 | The algal past and parasite present of the apicoplast |
| Q37948937 | The apicoplast: a red alga in human parasites |
| Q93122254 | The cat is out of the bag: How parasites know their hosts |
| Q36591627 | The cell biology of secondary endosymbiosis--how parasites build, divide and segregate the apicoplast |
| Q63363571 | The dense granule antigen, GRA2 of Toxoplasma gondii is a glycoprotein containing O-linked oligosaccharides |
| Q104609781 | The intestinal parasite Cryptosporidium is controlled by an enterocyte intrinsic inflammasome that depends on NLRP6 |
| Q36248040 | The intracellular parasite Toxoplasma gondii depends on the synthesis of long-chain and very long-chain unsaturated fatty acids not supplied by the host cell |
| Q106350463 | The iron-sulfur scaffold protein HCF101 unveils the complexity of organellar evolution in SAR, Haptista and Cryptista. |
| Q36293658 | The plastid of Toxoplasma gondii is divided by association with the centrosomes |
| Q34455762 | The toxoplasma apicoplast phosphate translocator links cytosolic and apicoplast metabolism and is essential for parasite survival |
| Q27673842 | Tic22 Is an Essential Chaperone Required for Protein Import into the Apicoplast |
| Q36869985 | Toxoplasma gondii Tic20 is essential for apicoplast protein import |
| Q27974636 | Toxoplasma gondii Toc75 Functions in Import of Stromal but not Peripheral Apicoplast Proteins |
| Q35022297 | Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin |
| Q34164615 | Toxoplasma gondii sequesters centromeres to a specific nuclear region throughout the cell cycle |
| Q36143585 | Two Essential Light Chains Regulate the MyoA Lever Arm To Promote Toxoplasma Gliding Motility |
| Q52690142 | Two essential Thioredoxins mediate apicoplast biogenesis, protein import, and gene expression in Toxoplasma gondii. |
| Q43719592 | Two glycoforms are present in the GPI-membrane anchor of the surface antigen 1 (P30) of Toxoplasma gondii. |
| Q37643702 | Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis |
| Q21145764 | What do human parasites do with a chloroplast anyway? |
| Q33193424 | cDNA cloning and expression of UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase T1 from Toxoplasma gondii |
Search more.